Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol

zu Verbundenen Objekten

Standort: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Umfang: Online-Ressource

Sprache: Englisch

Anmerkungen: online resource.

Erschienen in: Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol ; volume:16 ; number:1 ; day:23 ; month:5 ; year:2016 ; pages:1-8 ; date:12.2016
BMC cancer ; 16, Heft 1 (23.5.2016), 1-8, 12.2016

Urheber: Vogl, Thomas J.

Beteiligte Personen und Organisationen: Oppermann, Elsie
Qian, Jun
Imlau, Ulli
Tran, Andreas
Hamidavi, Yousef
Korkusuz, Huedayi
Bechstein, Wolf Otto
Nour-Eldin, Nour-Eldin Abdel-Rehim
Gruber-Rouh, Tatjana
Hammerstingl, Renate
Naguib, Nagy Naguib Naeem
SpringerLink (Online service)

DOI: 10.1186/s12885-016-2357-3

URN: urn:nbn:de:1111-201605257945

Rechteinformation: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Letzte Aktualisierung: 14.08.2025, 11:02 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Original beim Datenpartner anzeigen

Beteiligte

Vogl, Thomas J.
Oppermann, Elsie
Qian, Jun
Imlau, Ulli
Tran, Andreas
Hamidavi, Yousef
Korkusuz, Huedayi
Bechstein, Wolf Otto
Nour-Eldin, Nour-Eldin Abdel-Rehim
Gruber-Rouh, Tatjana
Hammerstingl, Renate
Naguib, Nagy Naguib Naeem
SpringerLink (Online service)

Ähnliche Objekte (12)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Konferenzschrift | Kongress

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Konferenzschrift | Kongress

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Konferenzschrift | Kongress

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Informationen zur Registrierung von Kultur- und Wissenseinrichtungen finden Sie hier.

Felder mit * müssen ausgefüllt werden.

Benutzername*

Bitte geben Sie Ihren Benutzernamen ein

E-Mail*

Bitte geben Sie Ihre E-Mail ein

Bitte füllen Sie dieses Feld nicht aus

Vorname

Nachname

Passwort*

Bitte geben Sie Ihr Passwort ein

Passwort bestätigen*

Bitte geben Sie das gleiche Passwort ein

Ich habe die Datenschutzerklärung zur Erhebung persönlicher Daten gelesen und stimme ihr zu.*

Dieses Feld ist ein Pflichtfeld.

Ich möchte den Newsletter der Deutschen Digitalen Bibliothek abonnieren. Siehe Informationen zum Newsletter-Abonnement.

Benutzerkonto angelegt

Ihr „Meine DDB“-Konto wurde erfolgreich angelegt. Bevor Sie sich in Ihrem Konto anmelden können, müssen Sie auf den Bestätigungslink in der Nachricht klicken, die wir gerade an die von Ihnen angegebene E-Mail-Adresse geschickt haben

Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol

Objekt anzeigen

Verweise und Beziehungen

Beteiligte, Orts- und Zeitangaben

Weitere Informationen

Datenpartner

Beteiligte

Ähnliche Objekte (12)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Crystal structure of (3,6-di (2-pyridyl)-4-methylphenyl pyridazine- k 2 N,N ′)-bis (1-phenyl-pyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 39 H 29 F 6 IrN 8 P

Crystal structure of (3,6-di (2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis (2-(p-toluene) pyridinyl-κ 2 C,N)-iridium (III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P

Gan zhuan yi ai zhen duan yu zhi liao

Crystal structure of (2-phenylimino methylquinoline- κ 2 N,N ′)-bis (1–phenylpyrazole- κ 2 C,N)-iridium (III) hexafluorophosphate, C 34 H 26 F 6 IrN 6 P

Crystal structure of (2-(2-pyridine)-benzimidazole- κ 2 N,N′)-bis (1-phenylpyrazole- κ 2 C,N) iridium (III) hexafluorophosphate, C 30 H 22 F 6 IrN 7 P

Crystal structure of poly (bis (μ 2 -2,6-bis (1-imidazoly) pyridine- κ 2 N:N ′) copper (II)) diperchlorate dihydrate, C 22 H 22 Cl 2 CuN 10 O 10

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Using Baidu search values to monitor and predict the confirmed cases of COVID-19 in China: – evidence from Baidu index

The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger

The diagnostic value of artificial intelligence-assisted imaging for developmental dysplasia of the hip: a systematic review and meta-analysis

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Verbundene Objekte

Passwort zurücksetzen